Andexanet alfa (Ondexxya®) accepted for use within NHS Scotland on interim basis subject to ongoing evaluation and future reassessment

Andexanet alfa intravenous infusion is approved for adult patients treated with a direct factor Xa inhibitor (apixaban or rivaroxaban) when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.


Scottish Medicines Consortium